RHS Financial »

BioCryst Pharmaceuticals shares owned by RHS Financial

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by RHS Financial from 13F filings

Historical chart of RHS Financial investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by RHS Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by RHS Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $190k 19k 10.00

More positions owned by RHS Financial

Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Fundamental Us L (FNDX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Mmentm (MTUM)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Intl Eqty Factor (INTF)
Ishares Emng Mkts Eqt (EMGF)
Schwab Strategic Tr Fund Em Equi Etf (FNDE)
Ishares Tr Msci Intl Moment (IMTM)
Ishares Tr U S Equity Factr (LRGF)
Apple (AAPL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ea Series Trust Alpha Arch 1-3 (BOXX)

View all positions for RHS Financial

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
TCG Crossover Management
Perceptive Advisors
Jupiter Topco
Henderson Group
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Standard Life Aberdeen
UBS Group

View all funds holding BioCryst Pharmaceuticals